ADVANCED CELL TECHNOLOGY
Biotechnology company focused on applying stem cell technology to regenerative medicine.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Report 4th Quarter 2010
|
FOLEY HOAG LLP | $45,000 reported |
|
3rd Quarter - Report 3rd Quarter 2010
|
FOLEY HOAG LLP | $30,000 reported |
|
Registration 3rd Quarter 2010
|
FOLEY HOAG LLP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| FOLEY HOAG LLP | 6 | $75,000 |
| GORDON C. JAMES PUBLIC RELATIONS | 1 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 6 |
| Science/Technology | SCI | 2 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.